α-Glucosidase inhibitors boost gut immunity by inducing IgA responses in Peyer's patches

Front Immunol. 2023 Nov 1:14:1277637. doi: 10.3389/fimmu.2023.1277637. eCollection 2023.

Abstract

Peyer's patches (PPs) are specialized gut-associated lymphoid tissues that initiate follicular helper T (Tfh)-mediated immunoglobulin A (IgA) response to luminal antigens derived from commensal symbionts, pathobionts, and dietary sources. IgA-producing B cells migrate from PPs to the small intestinal lamina propria and secrete IgA across the epithelium, modulating the ecological balance of the commensal microbiota and neutralizing pathogenic microorganisms. α-glucosidase inhibitors (α-GIs) are antidiabetic drugs that inhibit carbohydrate digestion in the small intestinal epithelium, leading to alterations in the commensal microbiota composition and metabolic activity. The commensal microbiota and IgA responses exhibit bidirectional interactions that modulate intestinal homeostasis and immunity. However, the effect of α-GIs on the intestinal IgA response remains unclear. We investigated whether α-GIs affect IgA responses by administering voglibose and acarbose to mice via drinking water. We analyzed Tfh cells, germinal center (GC) B cells, and IgA-producing B cells in PPs by flow cytometry. We also assessed pathogen-specific IgA responses. We discovered that voglibose and acarbose induced Tfh cells, GCB cells, and IgA-producing B cells in the PPs of the proximal small intestine in mice. This effect was attributed to the modification of the microbiota rather than a shortage of monosaccharides. Furthermore, voglibose enhanced secretory IgA (S-IgA) production against attenuated Salmonella Typhimurium. Our findings reveal a novel mechanism by which α-GIs augment antigen-specific IgA responses by stimulating Tfh-GCB responses in PPs, and suggest a potential therapeutic application as an adjuvant for augmenting mucosal vaccines.

Keywords: follicular helper T cell; immunoglobulin A; peyer’s patch; voglibose; α-glucosidase inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acarbose / metabolism
  • Animals
  • Antigens / metabolism
  • Glycoside Hydrolase Inhibitors* / metabolism
  • Glycoside Hydrolase Inhibitors* / pharmacology
  • Immunoglobulin A*
  • Mice
  • Peyer's Patches

Substances

  • Immunoglobulin A
  • Glycoside Hydrolase Inhibitors
  • Acarbose
  • voglibose
  • Antigens

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (20H05876, 20H00509, 22K19445, and 23H05482 to KH-M; 20K07552, and 23H04788 to DT); Japan Science and Technology Agency (JST) CREST grant (JPMJCR19H1 to KH-M); JST Moonshot R&D grant (JPMJMS2025 to KH-M); Japan Agency for Medical Research and Development (AMED) grant (22gm1310009h0003, and 23gm1310009h0004 to KH-M); The Asahi Grass Foundation research grant (KH-M and DT); Fuji Foundation for Protein Research (KH-M); Takeda Science Foundation research grant (KH-M); Kato Memorial Bioscience Foundation research grant (DT); Kobayashi Foundation research grant (DT); Suzuken Memorial Foundation research grant (DT), Kowa Life Science Foundation research grant (DT).